Squarepoint
INSM icon

Squarepoint’s Insmed INSM Stock Holding History

Squarepoint’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
33,900
-104,400
-75% -$12.6M ﹤0.01% 1863
2026
Q1 		$22.6M Buy
138,300
+134,100
+3,193% +$20.6M 0.03% 642
2025
Q4 		$731K Sell
4,200
-3,100
-42% -$566K ﹤0.01% 2880
2025
Q3 		$1.05M Sell
7,300
-1,300
-15% -$159K ﹤0.01% 2652
2025
Q2 		$866K Buy
+8,600
New +$658K ﹤0.01% 2793
2025
Q1 		– Sell
-30,800
Closed -$2.13M – 4986
2024
Q4 		$2.13M Buy
+30,800
New +$2.22M ﹤0.01% 2349

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Squarepoint's INSM Position: Q2 2026 in Review

Squarepoint increased its Insmed (INSM) stake by 1,468% in Q2 2026, buying an estimated $69.9M and bringing the position to 616,464 shares worth $65.7M. The position accounts for 0.07% of the portfolio, ranked #264.

Squarepoint first reported a position in INSM in Q4 2015 and has held it in 27 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Squarepoint held 616,464 shares of Insmed worth $65.7M as of Q2 2026.
  • Squarepoint bought 577,148 Insmed shares in Q2 2026, an estimated $69.9M.
  • Insmed made up 0.07% of Squarepoint's portfolio in Q2 2026, its #264 holding.
  • Squarepoint first reported a position in Insmed in Q4 2015 and has held it in 27 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.